Rapid Influenza Diagnostic Tests Market : Table of Content


  • Published On : Dec-2019 |
  • Pages : 242 Pages |
  • Format : Rapid Influenza Diagnostic Tests Market Rapid Influenza Diagnostic Tests Market Rapid Influenza Diagnostic Tests Market Rapid Influenza Diagnostic Tests Market

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Macro-Economic Factors

    3.2. Forecast Factors - Relevance & Impact

    3.3. Market Dynamics

        3.3.1. Opportunity Analysis

        3.3.2. Drivers

        3.3.3. Restraints

4. Market Context

    4.1. Disease Epidemiology

    4.2. Key Regulations

    4.3.  Value Chain Analysis

5. Global Rapid Influenza Diagnostic Tests Market Volume (Units) Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Volume (Units) Analysis, 2014-2018

    5.2. Current and Future Market Volume (Units) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

6. Global Rapid Influenza Diagnostic Tests Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Product Type

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Rapid Influenza Diagnostic Tests Market Demand (Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

    7.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    7.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

    7.3. Market Value Growth Comparison

8. Global Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029, by Principle 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Principle, 2014–2018

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Principle, 2019-2029

        8.3.1. Immunochromatographic Assays

        8.3.2. Immunofluorescence Assays

        8.3.3. Nucleic Acid Amplification Test (NAAT)

    8.4. Market Attractiveness Analysis By Principle

9. Global Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029, by Test Type 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Test Type, 2014–2018

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2019-2029

        9.3.1. Influenza A Test

        9.3.2. Influenza B Test

        9.3.3. Influenza A+B Test

    9.4. Market Attractiveness Analysis By Test Type

10. Global Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029, by Sample Type 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Sample Type, 2014–2018

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2019-2029

        10.3.1. Throat Swab

        10.3.2. Nasal Swab

        10.3.3. Nasal Aspirate

        10.3.4. Nasal Wash

        10.3.5. Nasopharyngeal Swab

        10.3.6. Nasopharyngeal Aspirate

        10.3.7. Nasopharyngeal Wash

        10.3.8. Others

    10.4. Market Attractiveness Analysis By Sample Type

11. Global Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By End User, 2014–2018

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2029

        11.3.1. Hospitals

        11.3.2. Diagnostic Centers

        11.3.3. Nursing Homes

        11.3.4. Office-based Settings

        11.3.5. Urgent Care Centers

        11.3.6. Retail Pharmacy Clinics

        11.3.7. Schools & Universities

        11.3.8. Public Health Camps

        11.3.9. Others (Cruise Ships, Correctional Facilities, etc.)

    11.4. Market Attractiveness Analysis By End User

12. Global Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014–2018

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East & Africa

    12.4. Market Attractiveness Analysis By Region

13. North America Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        13.3.1.  By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Principle

        13.3.3. By Test Type

        13.3.4. By Sample Type

        13.3.5. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Principle

        13.4.3. By Test Type

        13.4.4. By Sample Type

        13.4.5. By End User

14. Latin America Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        14.3.1.  By Country

            14.3.1.1. Mexico

            14.3.1.2. Argentina

            14.3.1.3. Rest of Latin America

        14.3.2. By Principle

        14.3.3. By Test Type

        14.3.4. By Sample Type

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Principle

        14.4.3. By Test Type

        14.4.4. By Sample Type

        14.4.5. By End User

15. Europe Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        15.3.1.  By Country

            15.3.1.1. U.K.

            15.3.1.2. Germany

            15.3.1.3. France

            15.3.1.4. Italy

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Rest of Europe

        15.3.2. By Principle

        15.3.3. By Test Type

        15.3.4. By Sample Type

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Principle

        15.4.3. By Test Type

        15.4.4. By Sample Type

        15.4.5. By End User

16. East Asia Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        16.3.1.  By Country

            16.3.1.1. Japan

            16.3.1.2. South Korea

        16.3.2. By Principle

        16.3.3. By Test Type

        16.3.4. By Sample Type

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Principle

        16.4.3. By Test Type

        16.4.4. By Sample Type

        16.4.5. By End User

17. South Asia Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        17.3.1.  By Country

            17.3.1.1. Indonesia

            17.3.1.2. Thailand

            17.3.1.3. Malaysia

            17.3.1.4. Rest of South Asia

        17.3.2. By Principle

        17.3.3. By Test Type

        17.3.4. By Sample Type

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Principle

        17.4.3. By Test Type

        17.4.4. By Sample Type

        17.4.5. By End User

18. Oceania Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Principle

        18.3.3. By Test Type

        18.3.4. By Sample Type

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Principle

        18.4.3. By Test Type

        18.4.4. By Sample Type

        18.4.5. By End User

19. Middle East and Africa Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014–2018

    19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2019-2029

        19.3.1.  By Country

            19.3.1.1. South Africa

            19.3.1.2. GCC Countries

            19.3.1.3. Rest of MEA

        19.3.2. By Principle

        19.3.3. By Test Type

        19.3.4. By Sample Type

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Principle

        19.4.3. By Test Type

        19.4.4. By Sample Type

        19.4.5. By End User

20. Emerging Countries Rapid Influenza Diagnostic Tests Market Analysis 2014-2018 and Forecast 2019-2029

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. India Rapid Influenza Diagnostic Tests Market Analysis

        20.2.1. Introduction

        20.2.2. Market Value Proportion Analysis by Market Taxonomy

        20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.2.3.1. By Principle

            20.2.3.2. By Test Type

            20.2.3.3. By Sample Type

            20.2.3.4. By End User

    20.3. Brazil  Rapid Influenza Diagnostic Tests Market Analysis

        20.3.1. Introduction

        20.3.2. Market Value Proportion Analysis by Market Taxonomy

        20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.3.3.1. By Principle

            20.3.3.2. By Test Type

            20.3.3.3. By Sample Type

            20.3.3.4. By End User

    20.4. China Rapid Influenza Diagnostic Tests Market Analysis

        20.4.1. Introduction

        20.4.2. Market Value Proportion Analysis by Market Taxonomy

        20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            20.4.3.1. By Principle

            20.4.3.2. By Test Type

            20.4.3.3. By Sample Type

            20.4.3.4. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies 

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Product foot print by Players

        21.4.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. SA Scientific

            22.3.1.1. Overview

            22.3.1.2. Service Portfolio

            22.3.1.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Service Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. 3M Company

            22.3.2.1. Overview

            22.3.2.2. Service Portfolio

            22.3.2.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Service Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Abbott

            22.3.3.1. Overview

            22.3.3.2. Service Portfolio

            22.3.3.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Service Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Becton, Dickinson & Company

            22.3.4.1. Overview

            22.3.4.2. Service Portfolio

            22.3.4.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Service Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. Biocartis N.V.

            22.3.5.1. Overview

            22.3.5.2. Service Portfolio

            22.3.5.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Service Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. BioFire Diagnostics (bioMerieux, Inc.)

            22.3.6.1. Overview

            22.3.6.2. Service Portfolio

            22.3.6.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Service Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. Biosynex S.A.

            22.3.7.1. Overview

            22.3.7.2. Service Portfolio

            22.3.7.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Service Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. Cepheid, Inc.

            22.3.8.1. Overview

            22.3.8.2. Service Portfolio

            22.3.8.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Service Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Creative Diagnostics

            22.3.9.1. Overview

            22.3.9.2. Service Portfolio

            22.3.9.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Service Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Focus Diagnostics (DiaSorin SpA)

            22.3.10.1. Overview

            22.3.10.2. Service Portfolio

            22.3.10.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Service Strategy

                22.3.10.5.3. Channel Strategy

        22.3.11. F. Hoffmann-La Roche

            22.3.11.1. Overview

            22.3.11.2. Service Portfolio

            22.3.11.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Service Strategy

                22.3.11.5.3. Channel Strategy

        22.3.12. GenMark Diagnostics

            22.3.12.1. Overview

            22.3.12.2. Service Portfolio

            22.3.12.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.12.4. Sales Footprint

            22.3.12.5. Strategy Overview

                22.3.12.5.1. Marketing Strategy

                22.3.12.5.2. Service Strategy

                22.3.12.5.3. Channel Strategy

        22.3.13. Hologic, Inc.

            22.3.13.1. Overview

            22.3.13.2. Service Portfolio

            22.3.13.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.13.4. Sales Footprint

            22.3.13.5. Strategy Overview

                22.3.13.5.1. Marketing Strategy

                22.3.13.5.2. Service Strategy

                22.3.13.5.3. Channel Strategy

        22.3.14. Luminex Corporation

            22.3.14.1. Overview

            22.3.14.2. Service Portfolio

            22.3.14.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.14.4. Sales Footprint

            22.3.14.5. Strategy Overview

                22.3.14.5.1. Marketing Strategy

                22.3.14.5.2. Service Strategy

                22.3.14.5.3. Channel Strategy

        22.3.15. Meridian Bioscience, Inc.

            22.3.15.1. Overview

            22.3.15.2. Service Portfolio

            22.3.15.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.15.4. Sales Footprint

            22.3.15.5. Strategy Overview

                22.3.15.5.1. Marketing Strategy

                22.3.15.5.2. Service Strategy

                22.3.15.5.3. Channel Strategy

        22.3.16. Princeton BioMeditech Corporation

            22.3.16.1. Overview

            22.3.16.2. Service Portfolio

            22.3.16.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.16.4. Sales Footprint

            22.3.16.5. Strategy Overview

                22.3.16.5.1. Marketing Strategy

                22.3.16.5.2. Service Strategy

                22.3.16.5.3. Channel Strategy

        22.3.17. QIAGEN N.V.

            22.3.17.1. Overview

            22.3.17.2. Service Portfolio

            22.3.17.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.17.4. Sales Footprint

            22.3.17.5. Strategy Overview

                22.3.17.5.1. Marketing Strategy

                22.3.17.5.2. Service Strategy

                22.3.17.5.3. Channel Strategy

        22.3.18. Quidel Corporation

            22.3.18.1. Overview

            22.3.18.2. Service Portfolio

            22.3.18.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.18.4. Sales Footprint

            22.3.18.5. Strategy Overview

                22.3.18.5.1. Marketing Strategy

                22.3.18.5.2. Service Strategy

                22.3.18.5.3. Channel Strategy

        22.3.19. Sekisui Diagnostics

            22.3.19.1. Overview

            22.3.19.2. Service Portfolio

            22.3.19.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.19.4. Sales Footprint

            22.3.19.5. Strategy Overview

                22.3.19.5.1. Marketing Strategy

                22.3.19.5.2. Service Strategy

                22.3.19.5.3. Channel Strategy

        22.3.20. Thermo Fisher Scientific, Inc.

            22.3.20.1. Overview

            22.3.20.2. Service Portfolio

            22.3.20.3. Profitability by Market Segments (Service/Channel/Region)

            22.3.20.4. Sales Footprint

            22.3.20.5. Strategy Overview

                22.3.20.5.1. Marketing Strategy

                22.3.20.5.2. Service Strategy

                22.3.20.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology


Table 01: Global Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product Type

Table 02: Global Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Principle

Table 03: Global Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis- and Opportunity Assessment 2014–2029, By Sample Type

Table 04: Global Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis- and Opportunity Assessment 2014–2029, By End User

Table 05: Global Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Region

Table 06: North America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 07: North America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 08: North America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 09: North America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 10: North America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 11: Latin America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 12: Latin America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 13: Latin America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 14: Latin America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 15: Latin America Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 17: Europe Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 18: Europe Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 19: Europe Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 20: Europe Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 21: Europe Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 22: East Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 23: East Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 24: East Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 25: East Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 16: East Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 26: South Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 27: South Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 28: South Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 29: South Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 30: South Asia Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 31: Oceania Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 32: Oceania Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 33: Oceania Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 34: Oceania Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 35: Oceania Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 36: MEA Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Country

Table 37: MEA Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 38: MEA Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 39: MEA Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 40: MEA Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 41: China Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 42: China Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 43: China Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 44: China Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 45: India Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 46: India Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 47: India Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 48: India Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User

Table 49: Brazil Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Product Type

Table 50: Brazil Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Principle

Table 51: Brazil Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By Sample Type

Table 52: Brazil Rapid Influenza Diagnostic Tests Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019–2029, By End User


Figure 01: Global Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 02: Global Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 03: Global Rapid Influenza Diagnostic Tests Market Absolute $ Opportunity, 2019 - 2029

Figure 04: Global Rapid Influenza Diagnostic Tests Market Share Analysis (%), By Principle, 2019 & 2029

Figure 05: Global Rapid Influenza Diagnostic Tests Market Y-o-Y Analysis (%), By Principle, 2019-2029

Figure 06: Global Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 07: Global Rapid Influenza Diagnostic Tests Market Share Analysis (%), By Test Type, 2019 & 2029

Figure 08: Global Rapid Influenza Diagnostic Tests Market Y-o-Y Analysis (%), By Test Type, 2019-2029

Figure 09: Global Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 10: Global Rapid Influenza Diagnostic Tests Market Share Analysis (%), By Sample Type, 2019 & 2029

Figure 11: Global Rapid Influenza Diagnostic Tests Market Y-o-Y Analysis (%), By Sample Type, 2019-2029

Figure 12: Global Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 13: Global Rapid Influenza Diagnostic Tests Market Share Analysis (%), By End User, 2019 & 2029

Figure 14: Global Rapid Influenza Diagnostic Tests Market Y-o-Y Analysis (%), By End User, 2019-2029

Figure 15: Global Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 16: Global Rapid Influenza Diagnostic Tests Market Share Analysis (%), By Region, 2019 & 2029

Figure 17: Global Rapid Influenza Diagnostic Tests Market Y-o-Y Analysis (%), By Region, 2019-2029

Figure 18: Global Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Region, 2019-2029

Figure 19: North America Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 20: North America Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 21: North America Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 22: North America Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 23: North America Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 24: North America Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 25: North America Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 26: North America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 27: North America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 28: North America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 29: North America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 30: North America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 31: Latin America Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 32: Latin America Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 33: Latin America Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 34: Latin America Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 35: Latin America Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 36: Latin America Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 37: Latin America Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 38: Latin America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 39: Latin America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 40: Latin America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 41: Latin America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 42: Latin America Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 43: Europe Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 44: Europe Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 45: Europe Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 46: Europe Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 47: Europe Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 48: Europe Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 49: Europe Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 50: Europe Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 51: Europe Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 52: Europe Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 53: Europe Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 54: Europe Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 55: East Asia Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 56: East Asia Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 57: East Asia Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 58: East Asia Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 59: East Asia Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 60: East Asia Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 61: East Asia Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 62: East Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 63: East Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 64: East Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 65: East Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 66: East Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 67: South Asia Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 68: South Asia Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 69: South Asia Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 70: South Asia Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 71: South Asia Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 72: South Asia Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 73: South Asia Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 74: South Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 75: South Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 76: South Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 77: South Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 78: South Asia Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 79: Oceania Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 80: Oceania Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 81: Oceania Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 82: Oceania Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 83: Oceania Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 84: Oceania Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 85: Oceania Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 86: Oceania Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 87: Oceania Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 88: Oceania Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 89: Oceania Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by End User, 2019-2029

Figure 90: Oceania Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 91: MEA Rapid Influenza Diagnostic Tests Market Value Share, By Principle, 2019 (E)

Figure 92: MEA Rapid Influenza Diagnostic Tests Market Value Share, By Test Type, 2019 (E)

Figure 93: MEA Rapid Influenza Diagnostic Tests Market Value Share, By Sample Type, 2019 (E)

Figure 94: MEA Rapid Influenza Diagnostic Tests Market Value Share, By End User, 2019 (E)

Figure 95: MEA Rapid Influenza Diagnostic Tests Market Value Share, By Country, 2019 (E)

Figure 96: MEA Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 97: MEA Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 98: MEA Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Principle, 2019-2029

Figure 99: MEA Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Test Type, 2019-2029

Figure 100: MEA Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Sample Type, 2019-2029

Figure 101: MEA Rapid Influenza Diagnostic Tests Market Attractiveness by End User, 2019-2029

Figure 102: MEA Rapid Influenza Diagnostic Tests Market Attractiveness Analysis by Country, 2019-2029

Figure 103: Rapid Influenza Diagnostic Tests Market, Emerging Countries Value Proportion Anlaysis, 2019 (E)

Figure 104: Rapid Influenza Diagnostic Tests Market, Global vs Emerging Countries Y-o-Y Growth Anlaysis, 2019-2029

Figure 105: China Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 106: China Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 107: India Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 108: India Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029

Figure 109: Brazil Rapid Influenza Diagnostic Tests Market Value Analysis (US$ Mn), 2014-2018

Figure 110: Brazil Rapid Influenza Diagnostic Tests Market Value Forecast (US$ Mn), 2019-2029 

Rapid Influenza Diagnostic Tests Market - Table of Content

Back To Top